Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2024

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ☒     Form 40-F  ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

 

 

 

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1

Notification of cessation of securities - ATH

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Alterity Therapeutics Limited
	By:	/s/ Geoffrey P. Kempler
		Geoffrey P. Kempler
		Chairman

 

Date: August 1, 2024

 

 

2

 

Exhibit 99.1

 

Appendix 3H - Notification of cessation of securities

 

Announcement Summary

 

 

 

Entity name

 

ALTERITY THERAPEUTICS LIMITED

 

Announcement Type

 

New announcement

 

Date of this announcement

 

Thursday August 01, 2024

 

Details of +securities that have ceased

 

ASX +security code		Security description		Number of +securities that have ceased				The +securities have ceased due to		Date of cessation
ATHAAF		OPTION EXPIRING 31-JUL-2024 EX $0.07			12,000,000			Expiry of option or other convertible security without exercise or conversion		31/07/2024

 

Refer to next page for full details of the announcement

 

Appendix 3H - Notification of cessation of securities

1 / 4

 

 

 

Appendix 3H - Notification of cessation of securities

 

Part 1 - Entity and announcement details

 

 

 

1.1	Name of +Entity

 

ALTERITY THERAPEUTICS LIMITED

 

We (the entity named above) provide the following information about our issued capital.

 

1.2 Registered number type		Registration number
ACN		080699065

 

1.3	ASX issuer code

 

ATH

 

1.4	The announcement is

 

New announcement

 

1.5	Date of this announcement

 

1/8/2024

 

Appendix 3H - Notification of cessation of securities

2 / 4

 

 

 

Appendix 3H - Notification of cessation of securities

 

Part 2 - Details of +equity securities or +debt securities that have ceased

 

 

 

ASX +Security Code and Description

 

ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07

 

Unquoted +equity securities that have ceased

 

Number of securities that have ceased

 

12,000,000

 

Reason for cessation

 

Expiry of option or other convertible security without exercise or conversion

 

Date of cessation		Is the entity paying any consideration for the cessation?
31/7/2024		No

 

Any other information the entity wishes to notify to ASX about the cessation? 

 

 

Appendix 3H - Notification of cessation of securities

3 / 4

 

 

 

Appendix 3H - Notification of cessation of securities

 

Part 3 - Issued capital following changes

 

 

 

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

 

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

 

3.1

Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

 

ASX +security code and description		Total number of +securities on issue
ATH : ORDINARY FULLY PAID			5,320,336,118
ATHO : OPTION EXPIRING 31-AUG-2026			932,706,668

 

3.2	Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

 

ASX +security code and description		Total number of +securities on issue
ATHAAI : OPTION EXPIRING 31-AUG-2024 EX $0.007			1,935,759,704
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375			14,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07			0
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238			11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09			35,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105			8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031			62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004			26,500,000
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003			120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032			91,392,720

 

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

 

Appendix 3H - Notification of cessation of securities

4 / 4

 

 

 

---